{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:34:33Z","timestamp":1707525273669},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"DOI":"10.7759\/cureus.45082","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T09:47:52Z","timestamp":1694512072000},"source":"Crossref","is-referenced-by-count":0,"title":["Determinants of Atrial Fibrillation Progression and Its Influence on Overall Mortality in a Cohort of Patients From South India"],"prefix":"10.7759","author":[{"given":"Pranathi","family":"Rudra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vamsi","family":"Krishna Krishnamaneni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praver","family":"Chandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep Kumar Reddy","family":"Bandakadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sathwik","family":"Billa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh SS","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, et al.. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014, 129:837-47. 10.1161\/CIRCULATIONAHA.113.005119","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(98)00583-9","article-title":"Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates","volume":"82","author":"Kannel WB","year":"1998","unstructured":"Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998, 82:2-9. 10.1016\/s0002-9149(98)00583-9","journal-title":"Am J Cardiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.595140","article-title":"Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence","volume":"114","author":"Miyasaka Y","year":"2006","unstructured":"Miyasaka Y, Barnes ME, Gersh BJ, et al.. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation. 2006, 114:119-25. 10.1161\/CIRCULATIONAHA.105.595140","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2009.07.022","article-title":"Increasing prevalence of atrial fibrillation and flutter in the United States","volume":"104","author":"Naccarelli GV","year":"2009","unstructured":"Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009, 104:1534-9. 10.1016\/j.amjcard.2009.07.022","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January CT","year":"2014","unstructured":"January CT, Wann LS, Alpert JS, et al.. 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014, 64:e1-76. 10.1016\/j.jacc.2014.03.022","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm AJ","year":"2010","unstructured":"Camm AJ, Kirchhof P, Lip GY, et al.. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010, 31:2369-429. 10.1093\/eurheartj\/ehq278","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof P","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al.. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016, 37:2893-962. 10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.09.001","article-title":"The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation","volume":"36","author":"Andrade JG","year":"2020","unstructured":"Andrade JG, Aguilar M, Atzema C, et al.. The 2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation. Can J Cardiol. 2020, 36:1847-1948. 10.1016\/j.cjca.2020.09.001","journal-title":"Can J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra M","year":"2018","unstructured":"Rienstra M, Hobbelt AH, Alings M, et al.. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018, 39:2987-96. 10.1093\/eurheartj\/ehx739","journal-title":"Eur Heart J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31257-0","article-title":"Stroke prevention in atrial fibrillation","volume":"388","author":"Freedman B","year":"2016","unstructured":"Freedman B, Potpara TS, Lip GY. Stroke prevention in atrial fibrillation. Lancet. 2016, 388:806-17. 10.1016\/S0140-6736(16)31257-0","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights","volume":"127","author":"Kornej J","year":"2020","unstructured":"Kornej J, B\u00f6rschel CS, Benjamin EJ, Schnabel RB. Epidemiology of atrial fibrillation in the 21st century: novel methods and new insights. Circ Res. 2020, 127:4-20. 10.1161\/CIRCRESAHA.120.316340","journal-title":"Circ Res"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo Y","year":"2012","unstructured":"Guo Y, Lip GY, Apostolakis S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012, 60:2263-70. 10.1016\/j.jacc.2012.04.063","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013253","article-title":"Should atrial fibrillation patients with only 1 nongender-related CHA2DS2-VASc risk factor be anticoagulated?","volume":"47","author":"Fauchier L","year":"2016","unstructured":"Fauchier L, Clementy N, Bisson A, Ivanes F, Angoulvant D, Babuty D, Lip GY. Should atrial fibrillation patients with only 1 nongender-related CHA2DS2-VASc risk factor be anticoagulated?. Stroke. 2016, 47:1831-6. 10.1161\/STROKEAHA.116.013253","journal-title":"Stroke"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2011.08.068","article-title":"Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation","volume":"59","author":"Shah RU","year":"2012","unstructured":"Shah RU, Freeman JV, Shilane D, Wang PJ, Go AS, Hlatky MA. Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2012, 59:143-9. 10.1016\/j.jacc.2011.08.068","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2015.04.026","article-title":"P-wave duration and the risk of atrial fibrillation: results from the Copenhagen ECG Study","volume":"12","author":"Nielsen JB","year":"2015","unstructured":"Nielsen JB, K\u00fchl JT, Pietersen A, et al.. P-wave duration and the risk of atrial fibrillation: results from the Copenhagen ECG Study. Heart Rhythm. 2015, 12:1887-95. 10.1016\/j.hrthm.2015.04.026","journal-title":"Heart Rhythm"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel RB","year":"2009","unstructured":"Schnabel RB, Sullivan LM, Levy D, et al.. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet. 2009, 373:739-45. 10.1016\/S0140-6736(09)60443-8","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2013.07.002","article-title":"Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score","volume":"10","author":"Bunch TJ","year":"2013","unstructured":"Bunch TJ, May HT, Bair TL, et al.. Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. Heart Rhythm. 2013, 10:1272-7. 10.1016\/j.hrthm.2013.07.002","journal-title":"Heart Rhythm"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.11.026","article-title":"Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry","volume":"128","author":"Boriani G","year":"2015","unstructured":"Boriani G, Laroche C, Diemberger I, et al.. Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. Am J Med. 2015, 128:509-18.e2. 10.1016\/j.amjmed.2014.11.026","journal-title":"Am J Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation","volume":"137","author":"Lip GY","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest. 2010, 137:263-72. 10.1378\/chest.09-1584","journal-title":"Chest"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euw242","article-title":"European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)","volume":"19","author":"Gorenek B","year":"2017","unstructured":"Gorenek B, Pelliccia A, Benjamin EJ, et al.. European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Europace. 2017, 19:190-225. 10.1093\/europace\/euw242","journal-title":"Europace"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/182260-determinants-of-atrial-fibrillation-progression-and-its-influence-on-overall-mortality-in-a-cohort-of-patients-from-south-india","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:15Z","timestamp":1707509175000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/182260-determinants-of-atrial-fibrillation-progression-and-its-influence-on-overall-mortality-in-a-cohort-of-patients-from-south-india"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.45082","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}